| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,583 |
4,296 |
$303K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,596 |
6,004 |
$257K |
| 36415 |
Collection of venous blood by venipuncture |
10,329 |
9,937 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
967 |
917 |
$17K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
276 |
273 |
$4K |
| 99000 |
|
6,274 |
6,040 |
$4K |
| 99442 |
|
88 |
87 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,736 |
3,323 |
$4K |
| 99401 |
|
177 |
171 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$2K |
| 90674 |
|
19 |
19 |
$613.32 |
| 90661 |
|
17 |
17 |
$377.59 |
| 90686 |
|
40 |
40 |
$245.32 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$202.23 |
| 96127 |
|
12 |
12 |
$54.13 |
| J0739 |
Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) |
25 |
25 |
$15.03 |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
340 |
331 |
$0.24 |
| 1159F |
|
495 |
456 |
$0.00 |
| 3077F |
|
107 |
105 |
$0.00 |
| 1160F |
|
490 |
452 |
$0.00 |
| 3725F |
|
100 |
98 |
$0.00 |
| 3078F |
|
186 |
181 |
$0.00 |
| 1036F |
|
436 |
385 |
$0.00 |
| 1034F |
|
408 |
356 |
$0.00 |
| 3074F |
|
255 |
248 |
$0.00 |
| 3079F |
|
114 |
112 |
$0.00 |
| 1126F |
|
68 |
68 |
$0.00 |
| 3075F |
|
65 |
64 |
$0.00 |
| 3008F |
|
413 |
395 |
$0.00 |
| 3080F |
|
28 |
28 |
$0.00 |